Skip to content

Jose Muñoz Aycart

1 paper in the library · publishing 2024

Papers

Sublingual Ketamine for Depression and Anxiety: A Retrospective Study of Real-World Clinical Outcomes

medRxiv Preprint Server January 30, 2024 Lauren N. Swanson, Lila S. Jones, Jose Muñoz Aycart et al. preprint

Repeated at-home ketamine treatments are effective for reducing symptoms of depression, generalized anxiety, and social anxiety, and they appear safe with limited adverse effects and low tendency for long-term use.